Molecular brace traps two cancer-driving proteins to suppress prostate cancer growth in preclinical tests

Coverage, in order

1. 10h ago
   
   Medical Xpress indie

   Molecular brace traps two cancer-driving proteins to suppress prostate cancer growth in preclinical tests

   Many modern cancer drugs typically target a specific protein or signaling pathway to treat tumors. Now, researchers at the University of Michigan Health Rogel Cancer Center are taking a new approach by throwing a molecular wrench into the machinery driving prostate cancer. In preclinical studies…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.